Multi-modal Quantitative Imaging of the Skin
Recruiting now
Conditions studied: Skin Cancer, Skin Diseases, Atopic Dermatitis, Psoriasis, Raynaud Disease, Diabetic Foot, Peripheral Arterial Disease
In brief
This clinical trial is about evaluating the suitability of multi-modal imaging technology, which covers virtually the entire body, to evaluate the possibility of screening and early detection of disease.
Key facts
- Study ID
- NCT06989216
- Run by
- HJN Sverige AB/Neko Health
- People needed
- 8000
- Starts
- 2023-02-01
- Expected to finish
- 2026-02-01
- Last updated by the study team
- 2025-05-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adult patients that are part of the regular healthcare patient flow at the investigational sites, or as separately invited to participate in this investigation.
- Patients with signed informed consent
You may not qualify if…
- Cognitive impairment
- Patients unable to understand the oral and written study information in Swedish or English
- Other severe disorder or terminal disease
- Patients unable to provide an informed consent
- Patients not able to keep balance, while standing up with closed eyes, without any aid
- Claustrophobic patients
Where it is running
- Atrium Health Care Centre — Stockholm, Sweden (enrolling)
- Neko Health Centre Regeringsgatan — Stockholm, Sweden (enrolling)
- Neko Health Centre Sibyllegatan — Stockholm, Sweden (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.